Search results

Page title matches

• Imipenem-relebactam
  *Also includes cilastatin, as per usual with imipenem
  432 bytes (49 words) - 10:02, 26 August 2020

Page text matches

• MexXY-OprM efflux pump
  ...in]], [[sulbenicillin]], [[cefsulodin]], [[ceftazidime]], [[oxacephem]], [[imipenem]], and [[aztreonam]])
  454 bytes (39 words) - 09:35, 15 September 2020
• Antipseudomonal antibiotics
  *** [[Imipenem]]
  683 bytes (45 words) - 22:47, 7 February 2022
• Multidrug-resistant Gram-negative bacteria
  *[[Imipenem-relebactam]] (really imipenem-cilastatin-relebactam): still awaiting Health Canada Drug Review
  1 KB (159 words) - 17:18, 2 October 2022
• Pseudomonas aeruginosa
  **Decreased or absent OprD porin: resistance to [[carbapenems]] ([[imipenem]] and [[meropenem]]) that may spare other β-lactams ...AB-OprM: resistance to [[fluoroquinolones]] and all [[β-lactams]] except [[imipenem]]
  4 KB (479 words) - 11:35, 11 July 2023
• Ochrobactrum anthropi
  * Susceptible to gentamicin, amikacin, imipenem, ceftriaxone, and cefoperazone
  450 bytes (43 words) - 08:37, 19 January 2021
• Lactobacillus
  ** However, one study noted susceptibility to [[imipenem]], [[piperacillin-tazobactam]], [[erythromycin]], and [[clindamycin]], but
  548 bytes (57 words) - 09:05, 4 August 2022
• Morganellaceae
  *Intrinsic reduced susceptibility to [[imipenem]]
  648 bytes (70 words) - 11:19, 8 October 2020
• Imipenem-relebactam
  *Also includes cilastatin, as per usual with imipenem
  432 bytes (49 words) - 10:02, 26 August 2020
• Burkholderia mallei
  *Treatment is with [[Is treated by::ceftazidime]], [[Is treated by::imipenem]], [[Is treated by::doxycycline]], or [[Is treated by::TMP-SMX]]
  490 bytes (51 words) - 08:20, 14 October 2020
• Acinetobacter lwoffii
  * [[Meropenem]] and [[imipenem]] are reliable, as are [[fluoroquinolones]], [[aminoglycosides]], [[minocyc
  699 bytes (66 words) - 07:08, 20 March 2024
• Mycobacterium abscessus
  ** [[Imipenem]] 1 g IV q12h or [[cefoxitin]] 8-12 g/day in 2-3 divided doses for 2 weeks,
  586 bytes (75 words) - 06:30, 14 August 2020
• Carbapenem-resistant organisms
  |[[imipenem-relebactam]] ...enemase) consider: [[ceftazidime-avibactam]], [[meropenem-vaborbactam]], [[imipenem-relebactam]], [[cefiderocol]]
  7 KB (848 words) - 08:58, 30 August 2022
• Antibiotics in sodium restriction
  | [[Imipenem]] || 1.71
  1 KB (117 words) - 21:15, 20 December 2019
• Delftia acidovorans
  ...reated with [[piperacillin-tazobactam]], [[meropenem]], [[ceftazidime]], [[imipenem]], [[aminoglycosides]], and [[fluoroquinolones]]
  1 KB (111 words) - 08:59, 26 May 2021
• Alcaligenes faecalis
  * Most reliable antibiotics are [[imipenem]], [[meropenem]], and [[ceftazidime]] (about 66% susceptible), followed by
  1 KB (124 words) - 12:35, 16 January 2023
• Nutritionally variant streptococci
  |Imipenem
  1 KB (109 words) - 15:28, 11 March 2022
• Intrinsic antibiotic resistance
  ![[Imipenem|IMI]] *The [[Morganellaceae]] may have elevated MICs to [[imipenem]], but should be reported as susceptible if susceptible in vitro
  5 KB (614 words) - 11:28, 18 February 2022
• Urinary tract infection
  ** Preferred: [[ertapenem]], [[meropenem]], [[imipenem-cilastatin]], [[ciprofloxacin]], [[levofloxacin]], or [[trimethoprim-sulfam ...(if susceptible), [[ceftazidime-avibactam]], [[meropenem-vaborbactam]], [[imipenem-cilastatin-relebactam]], [[cefiderocol]]
  4 KB (458 words) - 08:55, 30 August 2022
• Multidrug-resistant organism
  |[[imipenem]], [[meropenem]], [[doripenem]] |[[ertapenem]], [[imipenem]], [[meropenem]], [[doripenem]]
  7 KB (668 words) - 17:10, 2 October 2022
• Burkholderia cepacia complex
  ** [[Meropenem]] 1-2 g IV q8h and [[imipenem]] 1 g IV q8h
  1 KB (156 words) - 12:48, 6 February 2023

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)